To evaluate the tumor immune activity, we used a previously described technique employing ssGSEA (Barbie et al., 2009) based on the five immune expression signatures reorganized by Vesteinn et al. (Lek et al., 2016) including IFN-γ response (Wolf et al., 2014), lymphocyte infiltration (Calabro et al., 2009), macrophages/monocytes (Beck et al., 2009), TGF-β response (Teschendorff et al., 2010), wound healing (Chang et al., 2004). The gene discussed is TGFB1; the disease is neoplasm.